Clinical trial
A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration
NCT02141061 is registered in ClinicalTrials.gov with Repros Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration
- Lead sponsor
- Repros Therapeutics Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- June 30, 2014
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy